UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Sickle cell disease; a general overview

Netherlands journal of medicine, 2004-11, Vol.62 (10), p.364-374

2004

Volltextzugriff (PDF)

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

BJC Reports, 2024-06, Vol.2 (1), p.1-4, Article 45

2024

Volltextzugriff (PDF)

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Biochemical and biophysical research communications, 2009-12, Vol.390 (1), p.161-164

2009

Volltextzugriff (PDF)

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

Annals of hematology, 2005-05, Vol.84 (5), p.282-286

2005

Volltextzugriff (PDF)

An unusual craving

Netherlands journal of medicine, 2015-02, Vol.73 (2), p.96

2015

Volltextzugriff (PDF)

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Blood cells, molecules, & diseases, 2010-04, Vol.44 (4), p.229-232

2010

Volltextzugriff (PDF)

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica (Roma), 2008-05, Vol.93 (5), p.e42-e44

2008

Volltextzugriff (PDF)

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

Annals of hematology, 2003-02, Vol.82 (2), p.109-113

2003

Volltextzugriff (PDF)

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Annals of hematology, 2003-03, Vol.82 (3), p.171-174

2003

Volltextzugriff (PDF)

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

Clinical immunology (Orlando, Fla.), 2000-09, Vol.96 (3), p.264-268

2000

Volltextzugriff (PDF)

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Acta haematologica, 2008-01, Vol.120 (3), p.130-133

2008

Volltextzugriff (PDF)

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Acta haematologica, 2009-01, Vol.122 (1), p.64-69

2009

Volltextzugriff (PDF)

Folate status assessment and folic acid supplements in sickle cell disease

Journal of pediatric hematology/oncology, 2001-11, Vol.23 (8), p.548-548

2001

Volltextzugriff (PDF)

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Journal of pediatric hematology/oncology, 2000-03, Vol.22 (2), p.184-185

2000

Volltextzugriff (PDF)

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Haematologica (Roma), 2008-05, Vol.93 (5), p.757-760

2008

Volltextzugriff (PDF)

Sickle cell patients are characterized by a reduced glycocalyx volume

Haematologica (Roma), 2008-02, Vol.93 (2), p.307-308

2008

Volltextzugriff (PDF)

An unusual craving

The Netherlands journal of medicine, 2015, Vol.73 (2), p.96-96

2015

Volltextzugriff (PDF)

An urgent call to raise the bar in oncology

British journal of cancer, 2021-11, Vol.125 (11), p.1477-1485

2021

Volltextzugriff (PDF)

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Haematologica (Roma), 2013-11, Vol.98 (11), p.1797-1803

2013

Volltextzugriff (PDF)

Contemporary oncology trials, drug approvals and the physician-patient relationship

Lancet Regional Health - Americas (Online), 2022-07, Vol.11, p.100247-100247, Article 100247

2022

Volltextzugriff (PDF)

Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands

Journal of cancer policy, 2024-09, Vol.41, p.100493, Article 100493

2024

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

The New England journal of medicine, 2022-09, Vol.387 (12), p.1143-1144

2022

Volltextzugriff (PDF)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

Lancet Regional Health - Americas (Online), 2023-09, Vol.25, p.100584-100584, Article 100584

2023

Volltextzugriff (PDF)

N-acetylcysteine reduces oxidative stress in sickle cell patients

Annals of hematology, 2012-07, Vol.91 (7), p.1097-1105

2012

Volltextzugriff (PDF)

Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes

Biochimica et biophysica acta, 2011-11, Vol.1812 (11), p.1412-1417

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(25)
Adult
(20)
Female
(19)
Hematology
(18)
Male
(18)
Anemia, Sickle Cell - Blood
(16)
Middle Aged
(15)
Sickle Cell Disease
(12)
Anemia, Sickle Cell - Complications
(8)
Biological And Medical Sciences
(7)
Hematologic And Hematopoietic Diseases
(7)
Medical Sciences
(7)
Anemias. Hemoglobinopathies
(6)
Diseases Of Red Blood Cells
(6)
Oncology
(6)
Young Adult
(6)
General & Internal Medicine
(5)
Hemolysis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sickle cell disease; a general overview

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

An unusual craving

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Folate status assessment and folic acid supplements in sickle cell disease

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Sickle cell patients are characterized by a reduced glycocalyx volume

An unusual craving

An urgent call to raise the bar in oncology

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Contemporary oncology trials, drug approvals and the physician-patient relationship

Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands

Trastuzumab Deruxtecan in HER2-Low Breast Cancer

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

N-acetylcysteine reduces oxidative stress in sickle cell patients

Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes

Aktive Filter

Suchergebnisse filtern